cat. ?Legal statusRoutes InhalationThe combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and combivent used to treat sulfate (albuterol sulfate) used in the combivent used to treat of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler.

bromide and salbutamol sulfate combivent used to treat sulfate) used in the management of combivent used to treat obstructive pulmonary disease (COPD) combivent used to treat asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.[hide]v • d • eDrugs for obstructive combivent used to treat diseases: asthma/COPD combivent used to treat inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • Fenoterol • TerbutalineLong acting ?2-agonists (LABA): Bambuterol • Clenbuterol • Formoterol • Salmeterolother: Epinephrine • Isoproterenol • combivent used to treat Beclometasone • Budesonide • Ciclesonide • Fluticasone • combivent used to treat Ipratropium • TiotropiumMast cell stabilizers Cromoglicate • NedocromilXanthines Aminophylline • Theobromine • TheophyllineLeukotriene antagonists Montelukast • Pranlukast • ZafirlukastCombination products Budesonide/formoterol • Fluticasone/salmeterol • Ipratropium/salbutamolThis pharmacology-related article is a stub. You can help Wikipedia by expanding it.Retrieved from.

pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered.